Journals / Turkish Thoracic Journal / 2015 / Cilt: 16 - Sayı: 1

A Rare Cause of Chylothorax: Hennekam Syndrome

Şilotoraksın Nadir Bir Nedeni: Hennekam Sendromu

Pages
33–35
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was diagnosed as Hennekam syndrome due to face anomalies, lymphedema, epilepsy, chylothorax and mild mental retardation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hennekam syndrome was defined as a syndrome characterized by a new autosomal recessive, severe lymphedema in legs, face and genitalia with intestinal lymphangiectasia, various face anomalies and severe mental retardation.
📊
Key Findings & Data:A 21 years old male patient was examined due to bilateral pleural effusion.
💡
Conclusion & Impact:The patient was diagnosed as Hennekam syndrome due to face anomalies, lymphedema, epilepsy, chylothorax and mild mental retardation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hennekam syndrome was defined as a syndrome characterized by a new autosomal recessive, severe lymphedema in legs, face and genitalia with intestinal lymphangiectasia, various face anomalies and severe mental retardation. A 21 years old male patient was examined due to bilateral pleural effusion. There were edema in both legs and eyelids, swelling in the scrotum and operation scar, broad forehead and face, depressed nasal bridge, epicanthal folds and micrognathia in the physical examination. Chylothorax was diagnosed due to level of pleural triglyceride (650 mg/dL). Lymphatic flow delayed in both lower extremities in lymphoscintigraphy. The patient was diagnosed as Hennekam syndrome due to face anomalies, lymphedema, epilepsy, chylothorax and mild mental retardation.

Özet

Hennekam sendromu 1989da Hennekam ve arkadaşları tarafından otozomal resesif geçişli, bacaklar, yüz ve genitallerde şiddetli lenfödem ile birlikte intestinal lenfanjiektazi, çeşitli yüz anomalileri ve ağır mental retardasyon ile karakterize bir sendrom olarak tanımlanmıştır. Yirmi bir yaşında erkek hasta bilateral plevral efüzyon nedeni ile tetkik edildi. Fizik muayenede her iki bacağında ve göz kapaklarında ödem, skrotumda şişlik ve operasyon skarı, geniş alın ve yüz, basık burun kökü, epikantal kıvrım ve mikrognati mevcuttu. Plevral sıvıda trigliserit düzeyi (650 mg/dL) olması nedeni ile şilotoraks tanısı konuldu. Lenfosintigrafide; her iki alt extremitede lenfatik akımda gecikme saptandı. Yüz anomalileri, lenfödem, epilepsi, şilotoraks ve hafif mental retardasyon olması nedeni ile hastaya Hennekam sendromu tanısı konuldu.

🔖

Cite This Article

BEKTAŞ, H., BÜLBÜL, Y., ÖZSU, S., ÖZLÜ, T. (2015). A Rare Cause of Chylothorax: Hennekam Syndrome. Turkish Thoracic Journal, Cilt: 16 - Sayı: 1, 33–35. https://ajindex.com/articles/418153

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Al-Gazali LI, Hertecant J, Ahmed R, Khan NA, Padmanabhan R. Further delineation of Hennekam syndrome. Clin Dysmorphol 2003;12:227-32. [CrossRef] 2. Angle B, Hersh JH. Expansion of the phenotype in Hennekam syndrome: a case with new manifestations. AmJ Med Genet 1997;71:211-4. [CrossRef] 3. Erkan T, Kutlu T, Cullu F, et al. Hennekam syndrome. Arch Pediatr 1998;5:1344-6. [CrossRef] 4. Van Balkom ID, Alders M, Allanson J, et al. Lymphedemalymphangiectasia-mental retardation (Hennekam) syndrome: a review. Am J Med Genet 2002;112:412-21. [CrossRef] 5. Scarcella A, De Lucia A, Pasquariello MB, Gambardella P. Early death in two sisters with Hennekam syndrome. Am J Med Genet 2000;93:181-3.[CrossRef] 6. Bellini C, Mazzella M, Campisi C, et al. Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum. Lymphology 2004;37:22-30. 7. Nişli K, Öner N, Kayserili H, Ertuğrul T. A Case of Hennekam syndrome presenting with massive pericardial effusion. Türk Kardiyoloji Derneği Arş 2008;36:325. 8. Liou DZ, Warren H, Maher DP, et al. Midodrine: a novel therapeutic for refractory chylothorax. Chest 2013;144:1055-7. [CrossRef]